Gene · 2071
Papers2,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dynamic monitoring of circulating tumor DNA to analyze genetic characteristics and resistance profile of lorlatinib in ALK positive previously treated NSCLC. | Thorac Cancer | 2023 | 37265111 | PubTator, text mining | PubMed |
| Physical and optical properties of ternary lead-bismuth tellurite glass. | Heliyon | 2023 | 37260900 | PubTator, text mining | PubMed |
| Learning consistent subcellular landmarks to quantify changes in multiplexed protein maps. | Nat Methods | 2023 | 37248388 | PubTator, text mining | PubMed |
| Biomarker and genomic analyses reveal molecular signatures of non-cardioembolic ischemic stroke. | Signal Transduct Target Ther | 2023 | 37248226 | PubTator, text mining | PubMed |
| Mechanism of Immune Evasion in Mosquito-Borne Diseases. | Pathogens | 2023 | 37242305 | PubTator, text mining | PubMed |
| Brain Calcifications: Genetic, Molecular, and Clinical Aspects. | Int J Mol Sci | 2023 | 37240341 | PubTator, text mining | PubMed |
| DNA Repair Pathway in Ovarian Cancer Patients Treated with HIPEC. | Int J Mol Sci | 2023 | 37240218 | PubTator, text mining | PubMed |
| Case Report: Lung adenocarcinoma associated with germline ERCC2 frameshift mutation. | Front Oncol | 2023 | 37223679 | PubTator, text mining | PubMed |
| Development of a novel measure of advanced cancer patients' perceived utility of secondary germline findings from tumor genomic profiling. | PEC Innov | 2023 | 37214538 | PubTator, text mining | PubMed |
| Genetic variability of oxidative stress and DNA repair genes associated with pre-treatment cancer-related fatigue in women with breast cancer. | Support Care Cancer | 2023 | 37212918 | PubTator, text mining | PubMed |
| Interfacial modification in perovskite-based tandem solar cells. | Nano Converg | 2023 | 37209284 | PubTator, text mining | PubMed |
| Dynamic conformational switching underlies TFIIH function in transcription and DNA repair and impacts genetic diseases. | Nat Commun | 2023 | 37179334 | PubTator, text mining | PubMed |
| Diverse genetic spectrum among patients who met the criteria of hereditary breast, ovarian and pancreatic cancer syndrome. | J Gynecol Oncol | 2023 | 37170728 | PubTator, text mining | PubMed |
| Role of condensates in modulating DNA repair pathways and its implication for chemoresistance. | J Biol Chem | 2023 | 37164156 | PubTator, text mining | PubMed |
Clonal cytopenia of undetermined significance (CCUS)-associated reversion of donor-derived, transient αβ T-cell large granular clonal lymphocytosis, emerging post-transplant in a patient with a history of γδ T-cell large granular lymphocytic leukemia. | Cold Spring Harb Mol Case Stud | 2023 | 37160316 | PubTator, text mining | PubMed |
| Structural basis of transcription reduction by a promoter-proximal +1 nucleosome. | Mol Cell | 2023 | 37148879 | PubTator, text mining | PubMed |
| PTEN-negative endometrial cancer cells protect their genome through enhanced DDB2 expression associated with augmented nucleotide excision repair. | BMC Cancer | 2023 | 37142958 | PubTator, text mining | PubMed |
| Low level of BRCA2 in peripheral blood lymphocytes is associated with an increased risk for head and neck squamous cell carcinoma (HNSCC) in a population of North-East India: a case-control study. | Ecancermedicalscience | 2023 | 37113717 | PubTator, text mining | PubMed |
| Cisplatin in Ovarian Cancer Treatment-Known Limitations in Therapy Force New Solutions. | Int J Mol Sci | 2023 | 37108749 | PubTator, text mining | PubMed |
| The Current Status of DNA-Repair-Directed Precision Oncology Strategies in Epithelial Ovarian Cancers. | Int J Mol Sci | 2023 | 37108451 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2071/papers?page=9